The abortion pill mifepristone has been proven safe by millions of Americans over 25 years, and its restrictions threaten access particularly for vulnerable populations.
Our data shows that chemical abortion poses greater risks to women in real-world clinical use than revealed in the clinical trials of mifepristone and that the rate of serious adverse events from the chemical abortion regimen continues to grow in recent years.